Transgelin (TAGLN) is a mesenchymal protein involved in the EMT process and plays a regulatory role in a variety of cancers (Lees-Miller et al., 1987; Thompson et al., 2012; Naito et al., 2014). Here, TAGLN is linked to cancer.